8-K/A filed September 20, 2023, 7:59 PM ET ticker STAA CIK 0000718937

other material confidence high sentiment positive materiality 0.60

STAAR Surgical amends Investor Day slide: 2026E Adj. EBITDA ex. SBC range raised to $90M-$120M

STAAR SURGICAL CO

Adjusted EBITDA ex. SBC for 2026E corrected to $90M-$120M from previously stated $75M-$110M.
CapEx expected ~$20-$30M annually; 2026E free cash flow estimated at $75-$110M.
Clarification relates solely to slide 108 of the September 14, 2023 Investor Day presentation.
No other projections or statements from the original 8-K were amended.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.